Sensus Healthcare, Inc. (SRTS) earnings
SRTS earnings moved a median of +0.43% by the close. Quarterly and annual SRTS reports and results, each read against the price at its own news timestamp. Back to the SRTS overview →
34 measured SRTS earnings events.
Where these SRTS earnings landedvs 33 measured SRTS earnings reactions
| Middle 50% of SRTS earnings reactions | -1.53% to +2.70% |
|---|---|
| Median reaction (to close) | +0.43% |
| Measured reactions | 33 |
Point-in-time · zero look-ahead
Half of the 33 SRTS earnings events with a measured close landed between -1.53% and +2.70%; 55% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Sensus Healthcare, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.17% | -1.89% | |
| Sensus Healthcare Reports Second Quarter 2026 Financial Results and Business Highlights | Press release | +5.62% | +2.14% | |
| Sensus Healthcare to Report Second Quarter 2026 Financial Results and Hold Business Update Conference Call on August 13, 2026 | Press release | +0.00% | -0.68% | |
| Form 10-Q Sensus Healthcare, Inc. For: Mar 31 | SEC filing · Form 10-Q | — | -1.00% | |
| Sensus Healthcare Reports First Quarter 2026 Financial Results and Business Highlights | Press release | -1.30% | +0.33% | |
| Sensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026 | Press release | — | +0.00% | |
| Form 10-K Sensus Healthcare, Inc. For: Dec 31 | SEC filing · Form 10-K | — | +1.26% | |
| Sensus Healthcare Reports Fourth Quarter 2025 Financial Results Highlighted by Publication of Dedicated CPT Codes for SRT to Treat Non-Melanoma Skin Cancer | Press release | +4.88% | +5.75% | |
| Form 10-Q Sensus Healthcare, Inc. For: Sep 30 | SEC filing · Form 10-Q | — | -1.07% | |
| Sensus Healthcare Reports Third Quarter 2025 Financial Results | Press release | -1.23% | +20.00% | |
| Sensus Healthcare to Report Third Quarter 2025 Financial Results and Hold Business Update Conference Call on November 6 | Press release | +0.00% | +1.86% | |
| Form 10-Q Sensus Healthcare, Inc. For: Jun 30 | SEC filing · Form 10-Q | — | — | |
| Sensus Healthcare Reports Second Quarter 2025 Financial Results | Press release | +0.59% | +2.52% | |
| Sensus Healthcare to Report Second Quarter 2025 Financial Results and Hold Business Update Conference Call on August 7 | Press release | -0.84% | -2.65% | |
| Form 10-Q Sensus Healthcare, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.72% | -4.29% | |
| Sensus Healthcare Reports First Quarter 2025 Financial Results | Press release | -1.72% | -4.29% | |
| Sensus Healthcare to Report First Quarter 2025 Financial Results and Hold Business Update Conference Call on May 15 | Press release | -0.23% | +0.93% | |
| Form 10-K Sensus Healthcare, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.43% | +0.43% | |
| REVISED - Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter | Press release | +2.34% | +9.36% | |
| Form 10-Q Sensus Healthcare, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.75% | -1.02% | |
| Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter | Press release | -0.71% | +3.40% | |
| Sensus Healthcare to Host Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 14, 2024 | Press release | -0.90% | -4.48% | |
| Form 10-Q Sensus Healthcare, Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.07% | -1.53% | |
| Sensus Healthcare Reports Second Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Second Quarter | Press release | +0.87% | -1.84% | |
| Sensus Healthcare Issues Reminder That its Second Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, August 8, 2024 | Press release | -3.15% | -0.50% | |
| Sensus Healthcare to Host Second Quarter 2024 Financial Results and Business Update Conference Call on Thursday, August 8, 2024 | Press release | -1.41% | -2.03% | |
| Form 10-Q Sensus Healthcare, Inc. For: Mar 31 | SEC filing · Form 10-Q | +4.15% | +4.54% | |
| Sensus Healthcare Reports First Quarter 2024 Financial Results With Revenues up More than Three-fold | Press release | -6.22% | +9.75% | |
| Sensus Healthcare Issues Reminder That its First Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, May 9, 2024 | Press release | +2.41% | +0.60% | |
| Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024 | Press release | — | +1.23% | |
| Form 10-K Sensus Healthcare, Inc. For: Dec 31 | SEC filing · Form 10-K | +2.02% | +4.05% | |
| Form 10-Q Sensus Healthcare, Inc. For: Sep 30 | SEC filing · Form 10-Q | +5.85% | +9.29% | |
| Sensus Healthcare Reports Third Quarter 2023 Financial Results | Press release | +7.57% | +2.70% | |
| Sensus Healthcare to Host Third Quarter 2023 Financial Results and Business Update Conference Call on Thursday, November 9, 2023 | Press release | +0.92% | -3.67% |
Keep exploring
More SRTS: analyst actions → · SEC filings → · SRTS overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Entera Bio Ltd. - Ordinary Shares (ENTX) | 217 | 0.00% | 46% |
| Precipio, Inc. (PRPO) | 217 | +0.51% | 52% |
| Allied Healthcare Products, Inc. (AHPI) | 215 | 0.00% | 38% |
| Tactile Systems Technology, Inc. (TCMD) | 215 | +0.25% | 62% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.